Customer-Centric Approach for a Clinical Trial
At Athena Clinical Research, we are dedicated to putting patients and participants at the center of our clinical trial process. Our customer-centric approach ensures that the needs, preferences, and well-being of participants are prioritized at every stage of the research journey. We believe that by focusing on the customer experience, we can enhance engagement, satisfaction, and ultimately the success of our clinical trials. Our customer-centric approach is guided by the following principles:
Participant Engagement
We actively engage with participants throughout the clinical trial process, providing clear and transparent information about the study, procedures, and expectations. We encourage open communication, address any concerns or questions promptly, and involve participants in decision-making whenever possible.
Personalized Care
We recognize that each participant is unique and may have individual needs and preferences. We strive to provide personalized care and support to ensure that participants feel valued, respected, and well-cared for during their participation in the trial.
Accessibility and Convenience
We aim to make participation in the clinical trial as convenient and accessible as possible for participants. This includes flexible scheduling, convenient locations, and accommodations for special needs to minimize any barriers to participation.
Empowerment and Education
We empower participants by providing them with the knowledge and resources they need to make informed decisions about their participation in the trial. We offer educational materials, clear explanations of procedures, and opportunities for participants to ask questions and seek clarification.
Safety and Well-being
The safety and well-being of participants are our top priorities. We maintain strict adherence to ethical guidelines, safety protocols, and regulatory requirements to ensure the protection of participants throughout the trial. Any adverse events or concerns are addressed promptly and with sensitivity.
Feedback and Continuous Improvement
We actively seek feedback from participants to understand their experiences, preferences, and suggestions for improvement. This feedback is used to continuously enhance the customer experience and make adjustments to our processes to better meet the needs of participants.
Long-Term Relationships
We view participants as partners in the research process and aim to build long-term relationships based on trust, respect, and mutual benefit. We value the contributions of participants to advancing medical knowledge and seek to maintain ongoing communication and engagement beyond the trial period.
By adopting a customer-centric approach to clinical trials, we strive to create a positive and supportive environment for participants, enhance the quality of our research outcomes, and contribute to the overall success of the trial. Our commitment to customer-centricity reflects our dedication to putting patients first and ensuring a positive and meaningful experience for all participants in our clinical trials.
Clinical Trials Phases
Phase I
Study Participants: 20 to 100 healthy volunteers or people with the disease/condition.
Length of Study: Several months
Purpose: Safety and dosage
Approximately 70% of drugs move to the next phase
Phase II
Study Participants: Up to several hundred people with the disease/condition.
Length of Study: Several months to 2 years
Purpose: Efficacy and side effects
Approximately 33% of drugs move to the next phase
Phase III
Study Participants: 300 to 3,000 volunteers who have the disease or condition
Length of Study: 1 to 4 years
Purpose: Efficacy and monitoring of adverse reactions
Approximately 25-30% of drugs move to the next phase
Phase IV
Study Participants: Several thousand volunteers who have the disease/condition
Designing Clinical Trials
Researchers design clinical trials to answer specific research questions related to a medical product. These trials follow a specific study plan, called a protocol, that is developed by the researcher or manufacturer. Before a clinical trial begins, researchers review prior information about the drug to develop research questions and objectives. Then, they decide:
- Who qualifies to participate (selection criteria)
- How many people will be part of the study
- How long the study will last
- Whether there will be a control group and other ways to limit research bias
- How the drug will be given to patients and at what dosage
- What assessments will be conducted, when, and what data will be collected
- How the data will be reviewed and analyzed
Clinical trials follow a typical series from early, small-scale, Phase 1 studies to late-stage, large scale, Phase 3 studies.